Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Payables (2016 - 2020)

Historic Payables for Forte Biosciences (FBRX) over the last 5 years, with Q3 2020 value amounting to $1.5 million.

  • Forte Biosciences' Payables fell 9497.94% to $1.5 million in Q3 2020 from the same period last year, while for Sep 2020 it was $1.5 million, marking a year-over-year decrease of 9497.94%. This contributed to the annual value of $6.3 million for FY2019, which is 8545.83% up from last year.
  • Forte Biosciences' Payables amounted to $1.5 million in Q3 2020, which was down 9497.94% from $2.6 million recorded in Q2 2020.
  • Forte Biosciences' 5-year Payables high stood at $30.1 million for Q3 2019, and its period low was $1.5 million during Q2 2018.
  • Over the past 5 years, Forte Biosciences' median Payables value was $6.8 million (recorded in 2019), while the average stood at $7.5 million.
  • In the last 5 years, Forte Biosciences' Payables soared by 56160.26% in 2019 and then crashed by 9497.94% in 2020.
  • Quarter analysis of 5 years shows Forte Biosciences' Payables stood at $8.9 million in 2016, then rose by 3.21% to $9.2 million in 2017, then tumbled by 62.8% to $3.4 million in 2018, then soared by 85.46% to $6.3 million in 2019, then plummeted by 76.03% to $1.5 million in 2020.
  • Its Payables stands at $1.5 million for Q3 2020, versus $2.6 million for Q2 2020 and $6.6 million for Q1 2020.